Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial

BACKGROUND: Dual antiplatelet therapy (DAPT) with aspirin (ASP) and a P2Y(12) blocker is currently standard care after percutaneous coronary intervention (PCI) with stent insertion, and aims to inhibit platelet function in order to prevent stent thrombosis. The P2Y(12) blocker ticagrelor (TIC) has g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Baos, Sarah, Underwood, Wendy, Culliford, Lucy, Reeves, Barnaby C., Rogers, Chris A., Bowles, Ruth, Johnson, Tom, Baumbach, Andreas, Mumford, Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680755/
https://ncbi.nlm.nih.gov/pubmed/29121979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2277-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados